Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria


ANIK İ. , ÇABUK B. , Gokbel A., SELEK A. , Cetinarslan B. , ANIK Y. , et al.

WORLD NEUROSURGERY, cilt.108, ss.278-290, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 108
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.wneu.2017.08.182
  • Dergi Adı: WORLD NEUROSURGERY
  • Sayfa Sayısı: ss.278-290

Özet

BACKGROUND: Transsphenoidal surgery is the first-choice treatment for acromegaly. Postoperative remission is an important predictor of outcome. Various factors have been described as markers of remission: preoperative mean growth hormone (GH) and insulin-like growth factor-1 levels, cavernous sinus invasion, tumor size, extrapseudocapsular resection, and experience of the surgeon.